Company intelligence / Profile preview

Accure Acne

Boulder, Colorado, United States

Ownership: Private
Employees: ~31
Development stage: Other

Overview

The Accure Acne Laser System (1726 nm) is FDA-cleared and CE Marked for mild to severe inflammatory acne vulgaris, providing a non-pharmacological alternative with sustained lesion reduction (~70-80% at 6 months post-treatment, 95% patient satisfaction), supported by >6 IRB-approved clinical trials and >100 subjects treated. Four in-office treatments spaced ~1 month apart are typical, with excellent safety and broad efficacy across all skin types.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Quanta System (EU commercial distribution)MellingMedical (distribution to Federal health facilities)

Beyond the preview

Go deeper on Accure Acne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accure Acne.

Explore the full profile